van Andel, L <br/><br/>
Metabolite profiling of the novel anti-cancer agent, plitidepsin, in urine and faeces in cancer patients after administration of   [electronic resource] 

 -  Cancer chemotherapy and pharmacology  09 2018 
 - 441-455 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-018-3637-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carbon Radioisotopes<br/>Chromatography, Liquid<br/>Clinical Trials, Phase I as Topic<br/>Depsipeptides--administration & dosage<br/>Feces<br/>Humans<br/>Neoplasms--blood<br/>Peptides, Cyclic<br/>Tandem Mass Spectrometry